Oral Testosterone Undecanoate Capsules combined with Qilin Pills for late-onset hypogonadism in males
Abstract：Objective:To investigate the clinical effects of oral Testosterone Undecanoate Capsules (TUC) combined with Qilin Pills (QLP) on late-onset hypogonadism (LOH) in men.Methods:Sixty-three LOH patients meeting the inclusion criteria were randomly divided into a control group (aged [48.4 ± 6.2] yr,n =32) and an experimental group (aged [47.2 ± 5.6] yr,n =31)to be treated with oral TUC (80 mg,qd) and TUC + QLP (6g,tid),respectively,both for 3 months.Comparisons were made between the two groups of patients in the IIEF-5 scores,total testosterone (TT) levels,and scores in the Aging Males'Symptoms (AMS) scale before and after treatment.Results:After treatment,the patients of the experimental group,as compared with the controls,showed a significantly increased IIEF-5 score (21.7 ± 5.8 vs 15.9 ± 4.7,P ＜0.05) and TT level ([16.7 ± 2.2] vs [13.1 ±2.8] nmol/L,P ＜0.05),but a decreased AMS score (20.7 ± 5.7vs31.3±6.5,P ＜0.05).Conclusion:TUC combined with Qilin Pills has a better effect and a lower rate of adverse reactions than TUC used alone in the treatment of late-onset hypogonadism in males.
Keywords：Qilin PillsTestosterone Undecanoate Capsuleslate-onset hypogonadism
Publication Date：2017-05-02
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 455-458 )